Isolation of the neutralization ScFvs against HBV infection from the immunized population

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|16|10|902-910

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.16, Iss.10, 2015-01, pp. : 902-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Neutralization scFv Antibody against IL-1β Isolated from a NIPA-based Bacterial Display Library

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 6, 2013-07 ,pp. : 571-581

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in DNA vaccination against HBV infection

By Cova Lucyna  

Future Virology, Vol. 7, Iss. 2, 2012-02 ,pp. : 149-160

Future Medicine

Access to resources Recommend Favorite

Implications for antivirals in HBV infection

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Antiviral Drugs in the Prophylaxis of HBV Infection

By  

Current Medicinal Chemistry, Vol. 19, Iss. 35, 2012-12 ,pp. : 5940-5946

Bentham Science Publishers

Access to resources Recommend Favorite

Drug safety evaluation of adefovir in HBV infection

By Viganò Mauro   Lampertico Pietro   Colombo Massimo  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 809-818

Informa Healthcare

Access to resources Recommend Favorite